Literature DB >> 29593177

Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome.

Licht Miyamoto.   

Abstract

Familial Wolff-Parkinson-White (WPW) syndrome is an autosomal dominant inherited disease and consists of a small percentage of WPW syndrome which exhibits ventricular pre-excitation by development of accessory atrioventricular pathway. A series of mutations in PRKAG2 gene encoding gamma2 subunit of 5'AMP-activated protein kinase (AMPK) has been identified as the cause of familial WPW syndrome. AMPK is one of the most important metabolic regulators of carbohydrates and lipids in many types of tissues including cardiac and skeletal muscles. Patients and animals with the mutation in PRKAG2 gene exhibit aberrant atrioventricular conduction associated with cardiac glycogen overload. Recent studies have revealed "novel" significance of canonical pathways leading to glycogen synthesis and provided us profound insights into molecular mechanism of the regulation of glycogen metabolism by AMPK. This review focuses on the molecular basis of the pathogenesis of cardiac abnormality due to PRKAG2 mutation and will provide current overviews of the mechanism of glycogen regulation by AMPK. J. Med. Invest. 65:1-8, February, 2018.

Entities:  

Keywords:  5'AMP‐activated protein kinase; aberrant atrioventricular conduction; amilial Wolff‐Parkinson‐White Syndrome; glycogen; ventricular  pre‐excitation

Mesh:

Substances:

Year:  2018        PMID: 29593177     DOI: 10.2152/jmi.65.1

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  7 in total

1.  AKT-mTOR signaling-mediated rescue of PRKAG2 R302Q mutant-induced familial hypertrophic cardiomyopathy by treatment with β-adrenergic receptor (β-AR) blocker metoprolol.

Authors:  Jian Zhuo; Haihua Geng; Xiaohui Wu; Mengkang Fan; Hongzhuan Sheng; Jian Yao
Journal:  Cardiovasc Diagn Ther       Date:  2022-06

Review 2.  Storage diseases with hypertrophic cardiomyopathy phenotype.

Authors:  Luis Ruiz-Guerrero; Roberto Barriales-Villa
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

Review 3.  ArrhythmoGenoPharmacoTherapy.

Authors:  Arpad Tosaki
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

4.  p38γ and p38δ regulate postnatal cardiac metabolism through glycogen synthase 1.

Authors:  Ayelén M Santamans; Valle Montalvo-Romeral; Alfonso Mora; Juan Antonio Lopez; Francisco González-Romero; Daniel Jimenez-Blasco; Elena Rodríguez; Aránzazu Pintor-Chocano; Cristina Casanueva-Benítez; Rebeca Acín-Pérez; Luis Leiva-Vega; Jordi Duran; Joan J Guinovart; Jesús Jiménez-Borreguero; José Antonio Enríquez; María Villlalba-Orero; Juan P Bolaños; Patricia Aspichueta; Jesús Vázquez; Bárbara González-Terán; Guadalupe Sabio
Journal:  PLoS Biol       Date:  2021-11-10       Impact factor: 8.029

5.  GOing Forward With the Cardiac Conduction System Using Gene Ontology.

Authors:  Kan Yan Chloe Li; Andrew C Cook; Ruth C Lovering
Journal:  Front Genet       Date:  2022-03-02       Impact factor: 4.599

6.  Prenatal overgrowth and polydramnios: Would you think about Noonan syndrome?

Authors:  Benedetta Beltrami; Jacopo Cerasani; Alessandra Consales; Roberta Villa; Nicoletta Resta; Daria Carmela Loconte; Simona Boito; Luca Caschera; Laura Bassi; Lorenzo Colombo; Maria Iascone; Maria Francesca Bedeschi
Journal:  Clin Case Rep       Date:  2022-08-22

Review 7.  Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening.

Authors:  Paz Ovics; Danielle Regev; Polina Baskin; Mor Davidor; Yuval Shemer; Shunit Neeman; Yael Ben-Haim; Ofer Binah
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.